Topline results of the STRONG-HF trial point to significant clinical benefit from a strategy featuring early initiation and rapid uptitration of meds for patients hospitalized with heart failure.
It may seem counterintuitive, but a new trial testing extra sodium intake in patients receiving high-dose IV diuretics for acute HF challenges routine use of salt restriction in that setting.
Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home
Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.